Facebook
Twitter
LinkedIn
Forward
Multiple Sclerosis Symposium Clinical Advances of Multiple Sclerosis Diagnosis and Treatment
Multiple Sclerosis is the second leading cause of disability in young adults 25-50 years old. A comprehensive approach to disease identification and management is required to navigate myriad complexities of this disease. Our course will highlight practice specifications, most up-to-date treatment protocols, recent advances in the field and physical therapy evaluation and management. Presentations will refer to current literature, technical developments, methodologies, and clinical efficacy. The information presented will aid collaboration between neurology practices to increase clinical acumen on MS and other neuro-immunological conditions that may mimic this disease, fine tune the clinical and radiographic assessment process for diagnosis and provide information on outcome and long-term management standards.
Target Audience
The conference is designed for advanced professionals involved in treating patients with multiple sclerosis and other neuro-immunological disorders including, but not limited to, Neurologists, PM&R physicians, Advanced Practice Providers, Nursing staff and Physical Therapists. Medical students, Residents and Fellows are also invited.
Learning Objectives
Identify lesions on imaging (MRIs) typical for MS diagnosis.
Differentiation of MS mimickers on imaging studies.
First line serum and CSF studies to order and how to interpret test results in the diagnosis of MS.
First line inpatient treatment of acute exacerbation/relapse of known MS patients.
First line inpatient treatment for newly diagnosed MS patients.
Utilize community resources to support mental health associated with newly diagnosed MS; socioeconomic issues related to treatment of MS.
Enroll patients in studies both local, continental and global research studies to enhance understanding of MS outcomes.
COURSE DIRECTOR
INGRID LOMA-MILLER, MD
Assistant Professor of Neurology and Assistant Division Chief of MS/Neuroimmunology UPMC Magee-Womens Hospital
COURSE CO-DIRECTOR
EMILY GUERRIERO PA-C
Supervisor Physician Assistant of Neurology MS Care Center/Neuroimmunology
UPMC Magee-Womens Hospital
DARCY BONAVENTURA, PT, DPT
Board-certified Neurologic Clinical Specialist
PT Program Director, UPMC Rehabilitation
Joseph Mettenburg, MD PhD
Neuroradiologist and Diagnostic Radiologist
UPMC
ROCK HEYMAN, MD
Director of the MS Care Center and Chief of the Division of Neuroimmunology
UPMC Magee-Womens Hospital
CIGDEM ISITAN ALKAWADRI, MD
Assistant Professor of Neurology MS Care Center and Co-director Fellowship Program
UPMC Magee-Womens Hospital
HOLLY APPLEBERRY, DO, MBA
Assistant Professor of Neurology MS Care Center Division of Neuroimmunology
UPMC Magee-Womens Hospital
JENNY LINNOILA, MD, PhD
Neurology Faculty MS Care Center Division of Neuroimmunology
UPMC Magee-Womens Hospital
This activity is approved for the following credit: AMA PRA Category 1 Credit™, ANCC, and AAPA Category 1 CME. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 0.00 AAPA Category I CME
- 0.00 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 0.00 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 0.00 Attendance